These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8965166)

  • 1. Technetium-99m radiolabeling using a phage-derived single-chain Fv with a C-terminal cysteine.
    Verhaar MJ; Keep PA; Hawkins RE; Robson L; Casey JL; Pedley B; Boden JA; Begent RH; Chester KA
    J Nucl Med; 1996 May; 37(5):868-72. PubMed ID: 8965166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical characterization and in vivo imaging studies of an engineered recombinant technetium-99m-labeled metallothionein-containing anti-carcinoembryonic antigen single-chain antibody.
    Pietersz GA; Patrick MR; Chester KA
    J Nucl Med; 1998 Jan; 39(1):47-56. PubMed ID: 9443738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 99mTc-labeled divalent and tetravalent CC49 single-chain Fv's: novel imaging agents for rapid in vivo localization of human colon carcinoma.
    Goel A; Baranowska-Kortylewicz J; Hinrichs SH; Wisecarver J; Pavlinkova G; Augustine S; Colcher D; Booth BJ; Batra SK
    J Nucl Med; 2001 Oct; 42(10):1519-27. PubMed ID: 11585867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo targeting of malignant melanoma by 125Iodine- and 99mTechnetium-labeled single-chain Fv fragments against high molecular weight melanoma-associated antigen.
    Kang N; Hamilton S; Odili J; Wilson G; Kupsch J
    Clin Cancer Res; 2000 Dec; 6(12):4921-31. PubMed ID: 11156253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalytic activity of an in vivo tumor targeted anti-CEA scFv::carboxypeptidase G2 fusion protein.
    Bhatia J; Sharma SK; Chester KA; Pedley RB; Boden RW; Read DA; Boxer GM; Michael NP; Begent RH
    Int J Cancer; 2000 Feb; 85(4):571-7. PubMed ID: 10699932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiolabelling of glycosylated MFE-23::CPG2 fusion protein (MFECP1) with 99mTc for quantitation of tumour antibody-enzyme localisation in antibody-directed enzyme pro-drug therapy (ADEPT).
    Francis RJ; Mather SJ; Chester K; Sharma SK; Bhatia J; Pedley RB; Waibel R; Green AJ; Begent RH
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1090-6. PubMed ID: 15029458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo comparison of binding of 99m-Tc-labeled anti-CEA MAb F33-104 with 99m-Tc-labeled anti-CEA MAb BW431/26.
    Watanabe N; Oriuchi N; Sugiyama S; Kuroki M; Matsuoka Y; Tanada S; Murata H; Inoue T; Sasaki Y
    Nuklearmedizin; 1999; 38(4):115-9. PubMed ID: 10392376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved tumor targeting with chemically cross-linked recombinant antibody fragments.
    King DJ; Turner A; Farnsworth AP; Adair JR; Owens RJ; Pedley RB; Baldock D; Proudfoot KA; Lawson AD; Beeley NR
    Cancer Res; 1994 Dec; 54(23):6176-85. PubMed ID: 7954464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of tumor angiogenesis using 99mTc-labeled human recombinant anti-ED-B fibronectin antibody fragments.
    Berndorff D; Borkowski S; Moosmayer D; Viti F; Müller-Tiemann B; Sieger S; Friebe M; Hilger CS; Zardi L; Neri D; Dinkelborg LM
    J Nucl Med; 2006 Oct; 47(10):1707-16. PubMed ID: 17015908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy and tumor-targeting kinetics of complete versus fragmented 99mTc-labeled anti-carcinoembryonic antigen antibodies: an intraindividual comparison.
    Behr TM; Becker WS; Klein MW; Bair HJ; Scheele JR; Wolf FG
    Cancer Res; 1995 Dec; 55(23 Suppl):5786s-5793s. PubMed ID: 7493347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation of an "instant" 99mTc-labeling kit for antibody imaging.
    Hansen HJ; Jones AL; Sharkey RM; Grebenau R; Blazejewski N; Kunz A; Buckley MJ; Newman ES; Ostella F; Goldenberg DM
    Cancer Res; 1990 Feb; 50(3 Suppl):794s-798s. PubMed ID: 2297726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium-99m labeling of murine monoclonal antibody fragments.
    Rhodes BA; Zamora PO; Newell KD; Valdez EF
    J Nucl Med; 1986 May; 27(5):685-93. PubMed ID: 3086522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site: technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptide.
    George AJ; Jamar F; Tai MS; Heelan BT; Adams GP; McCartney JE; Houston LL; Weiner LM; Oppermann H; Peters AM
    Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8358-62. PubMed ID: 7667295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scintigraphic detection of xenografted renal tumor by anti-renal cancer monoclonal antibody radiolabeled with technetium-99m.
    Mitsui K; Taki T; Miyagawa Y; Yamada Y; Honda N; Fukatsu H; Yoshikawa K; Segawa A
    Hinyokika Kiyo; 1995 Aug; 41(8):593-601. PubMed ID: 7572438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex.
    Waibel R; Alberto R; Willuda J; Finnern R; Schibli R; Stichelberger A; Egli A; Abram U; Mach JP; Plückthun A; Schubiger PA
    Nat Biotechnol; 1999 Sep; 17(9):897-901. PubMed ID: 10471933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing renal accumulation of single-chain Fv against melanoma-associated proteoglycan by coadministration of L-lysine.
    Hamilton S; Odili J; Wilson GD; Kupsch JM
    Melanoma Res; 2002 Aug; 12(4):373-9. PubMed ID: 12170187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc.
    Goldenberg DM; Goldenberg H; Sharkey RM; Higginbotham-Ford E; Lee RE; Swayne LC; Burger KA; Tsai D; Horowitz JA; Hall TC
    Cancer Res; 1990 Feb; 50(3 Suppl):909s-921s. PubMed ID: 2297741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semiquantitative SPECT tumor uptake of technetium-99m-labeled anti-CEA monoclonal antibody in colorectal tumor.
    Oriuchi N; Endo K; Watanabe N; Sugiyama S; Asao T; Takenoshita S; Nagamachi Y; Baum RP
    J Nucl Med; 1995 Apr; 36(4):679-83. PubMed ID: 7699464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hexa-histidine tag as a novel alternative for one-step direct labelling of a single-chain Fv antibody fragment with 99m Tc.
    Pimentel GJ; Vázquez JE; Quesada W; Felipe Y; Carderón C; Freyre FM; Oliva JP; Gavilondo JV
    Nucl Med Commun; 2001 Oct; 22(10):1089-94. PubMed ID: 11567181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiolations, 99mTc labelings, and animal in vivo biodistributions of divalent monoclonal antibody fragments.
    Govindan SV; Goldenberg DM; Grebenau RC; Hansen HJ; Griffiths GL
    Bioconjug Chem; 1996; 7(3):290-7. PubMed ID: 8816950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.